What is he best known for?
The fields of study he is best known for:
Thomas Kieber-Emmons spends much of his time researching Antibody, Antigen, Molecular biology, Epitope and Peptide.
Antigen is closely attributed to Immune system in his study.
Immunology covers Thomas Kieber-Emmons research in Immune system.
The Molecular biology study which covers Regulation of gene expression that intersects with Breast cancer, Cancer cell and Subcellular localization.
His Epitope research incorporates themes from Computational biology, Drug discovery and Virology.
His studies deal with areas such as Immunoglobulin light chain, Peptide sequence, Hypervariable region and Monoclonal antibody as well as Peptide.
His most cited work include:
- Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. (289 citations)
- Adjuvant‐dependent modulation of Th1 and Th2 responses to immunization with β‐amyloid (281 citations)
- Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. (171 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Antibody, Antigen, Immunology, Immune system and Biochemistry.
His Antibody research includes elements of Molecular biology, Breast cancer and Virology.
His Antigen research is multidisciplinary, relying on both T cell and Peptide.
His work investigates the relationship between Immunology and topics such as Cancer that intersect with problems in Cancer research, Methylation and Oncology.
The Immune system study combines topics in areas such as B cell and Glycan.
His Peptide sequence research is multidisciplinary, incorporating elements of Protein structure, Stereochemistry and Immunoglobulin light chain.
He most often published in these fields:
- Antibody (34.55%)
- Antigen (34.09%)
- Immunology (26.82%)
What were the highlights of his more recent work (between 2012-2021)?
- Immunology (26.82%)
- Antibody (34.55%)
- Cancer (13.64%)
In recent papers he was focusing on the following fields of study:
Thomas Kieber-Emmons mainly focuses on Immunology, Antibody, Cancer, Breast cancer and Immune system.
His work on Monoclonal antibody as part of general Antibody study is frequently linked to Context, therefore connecting diverse disciplines of science.
His work deals with themes such as Peptide, Metabolism and Virology, which intersect with Monoclonal antibody.
His biological study spans a wide range of topics, including Cancer research, Immunization, Transfection and Phases of clinical research.
Within one scientific family, he focuses on topics pertaining to Cell growth under Transfection, and may sometimes address concerns connected to Molecular biology.
His Immune system study also includes fields such as
- B cell which intersects with area such as T cell, Autoimmunity and Peptide library,
- Cell biology, Complementarity, Peptide sequence and Protein structure most often made with reference to Glycan.
Between 2012 and 2021, his most popular works were:
- Relevance of Pathological Complete Response after Neoadjuvant Therapy for Breast Cancer (41 citations)
- Tumor-Associated Glycans and Immune Surveillance (29 citations)
- Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells (27 citations)
In his most recent research, the most cited papers focused on:
Thomas Kieber-Emmons mostly deals with Antigen, Breast cancer, Immunology, Cancer and Computational biology.
His research integrates issues of Innate immune system, Immune system and Chemotherapy in his study of Antigen.
His work in the fields of Immunotherapy and Active immunotherapy overlaps with other areas such as Population.
His Breast cancer research also works with subjects such as
- Tumor progression, which have a strong connection to Methylation and Molecular biology,
- Bioinformatics together with Molecular mimicry, Complementarity and Peptide sequence.
In the subject of general Immunology, his work in Antibody, Immunogenicity, Vaccination and Immune tolerance is often linked to Classical complement pathway, thereby combining diverse domains of study.
His work in the fields of Antibody, such as Monoclonal antibody, intersects with other areas such as Context.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
